Richard C. Young & Co., Ltd. Novartis Ag Transaction History

Richard C. Young & Co., Ltd.

$860 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$95.27 - $108.47 $529,320 - $602,659	-5,556 Reduced 4.05%	131,600 $12.7 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $273,765 - $301,269	-2,967 Reduced 2.12%	137,156 $13.8 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $249,708 - $277,122	-2,636 Reduced 1.85%	140,123 $14.3 Million
Q2 2023 Aug 08, 2023	BUY	$92.52 - $104.91 $29,791 - $33,781	322 Added 0.23%	142,759 $14.4 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $133,730 - $155,085	1,671 Added 1.19%	142,437 $13.1 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $29,615 - $36,267	-392 Reduced 0.28%	140,766 $12.8 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $72,520 - $84,816	-972 Reduced 0.68%	141,158 $10.7 Million
Q2 2022 Aug 03, 2022	BUY	$80.52 - $93.75 $138,816 - $161,625	1,724 Added 1.23%	142,130 $12 Million
Q1 2022 May 06, 2022	BUY	$80.11 - $90.62 $681,255 - $770,632	8,504 Added 6.45%	140,406 $12.3 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $399,775 - $442,060	-5,016 Reduced 3.66%	131,902 $11.5 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $28,786 - $33,489	-352 Reduced 0.26%	136,918 $11.2 Million
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $268,846 - $296,949	3,154 Added 2.35%	137,270 $12.5 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $684,700 - $807,454	8,200 Added 6.51%	134,116 $11.5 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $531,578 - $642,973	6,809 Added 5.72%	125,916 $11.9 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $384,168 - $425,607	4,677 Added 4.09%	119,107 $10.4 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $187,676 - $211,260	-2,319 Reduced 1.99%	114,430 $9.99 Million
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $324,445 - $454,554	4,591 Added 4.09%	116,749 $9.63 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $203,367 - $229,937	2,411 Added 2.2%	112,158 $10.6 Million
Q3 2019 Oct 29, 2019	BUY	$85.54 - $94.26 $77,841 - $85,776	910 Added 0.84%	109,747 $9.54 Million
Q2 2019 Aug 06, 2019	BUY	$75.4 - $92.8 $941,972 - $1.16 Million	12,493 Added 12.97%	108,837 $9.94 Million
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $7.26 Million - $8.3 Million	96,344 New	96,344 $9.26 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard C. Young & Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Richard C. Young & Co., Ltd. with notifications on news.

Account